All Stories

  1. Emerging Biomarkers in the Era of Personalized Cancer Medicine

    Article • Disease Markers, August 2019, Hindawi Publishing Corporation

    Biagio Ricciuti

  2. Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence

    Article • OncoTargets and Therapy, April 2019, Dove Medical Press

    Biagio Ricciuti

  3. Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience

    Article • Therapeutic Advances in Respiratory Disease, January 2018, SAGE Publications

    Biagio Ricciuti

  4. Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

    Article • Therapeutic Advances in Medical Oncology, April 2017, SAGE Publications

    Biagio Ricciuti

  5. Malignant Giant Solitary Fibrous Tumor of the Pleura Metastatic to the Thyroid Gland

    Article • Tumori Journal, November 2016, SAGE Publications

    Biagio Ricciuti